Human medicines European Public Assessment Report (EPAR): Refludan, lepirudin, Revision: 15, Withdrawn
Related Biotechnology, Pharmaceutical and Healthcare News
- Human medicines European Public Assessment Report (EPAR): Pelzont, laropiprant / nicotinic acid, Revision: 11, Withdrawn
- Human medicines European Public Assessment Report (EPAR): Tredaptive, laropiprant / nicotinic acid, Revision: 11, Withdrawn
- Human medicines European Public Assessment Report (EPAR): Trevaclyn, laropiprant / nicotinic acid, Revision: 11, Withdrawn
- Human medicines European Public Assessment Report (EPAR): Bondenza (previously Ibandronic Acid Roche), ibandronic acid, Revision: 16, Withdrawn
- Human medicines European Public Assessment Report (EPAR): Incivo, telaprevir, Revision: 7, Authorised
Original Article: Human medicines European Public Assessment Report (EPAR): Refludan, lepirudin, Revision: 15, Withdrawn
NEXT ARTICLE
More From BioPortfolio on "Human medicines European Public Assessment Report (EPAR): Refludan, lepirudin, Revision: 15, Withdrawn"
Search BioPortfolio: